Pfizer, YaoPharma Partner on GLP-1 Drug for Weight Management
Pfizer has entered into a global collaboration and licensing agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, to advance the development of YP05002, an…
Read More...
Read More...
